Inari Medical, Inc. Common Stock

NARI

...

NARI: Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism. The company generates revenue from the sale of ClotTriever and FlowTriever systems directly to hospitals located in the United States. Majority of revenue is generated from FlowTriever system.

Show NARI Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of NARI by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NARI's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Hemostasis valves and methods of use Jul. 11, 2023
Patent Title: Hemostasis valves and methods of use Jul. 11, 2023
Patent Title: Methods and apparatus for treating embolism May. 16, 2023
Patent Title: System for treating embolism and associated devices and methods May. 09, 2023
Patent Title: System for treating embolism and associated devices and methods Jan. 24, 2023
Patent Title: System for treating embolism and associated devices and methods Jan. 17, 2023
Patent Title: Method for treating vascular occlusion Dec. 20, 2022
Patent Title: Catheter shaft and associated devices, systems, and methods Sep. 06, 2022
Patent Title: Single insertion delivery system for treating embolism and associated systems and methods Oct. 26, 2021
Patent Title: Device and method for treating vascular occlusion Oct. 19, 2021
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Jul. 13, 2021
Patent Title: Methods and apparatus for treating embolism Jul. 13, 2021
Patent Title: Hemostasis valves and methods of use May. 11, 2021
Patent Title: Devices and methods for treating vascular occlusion Feb. 09, 2021
Patent Title: Methods and apparatus for treating embolism Jul. 14, 2020
Patent Title: Methods and apparatus for treating embolism Mar. 17, 2020
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Jan. 07, 2020
Patent Title: Retraction and aspiration device for treating embolism and associated systems and methods Jul. 16, 2019
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Jul. 09, 2019
Patent Title: Methods and apparatus for treating embolism Jul. 02, 2019
Patent Title: Methods and apparatus for treating embolism Mar. 26, 2019
Patent Title: Devices and methods for treating vascular occlusion Oct. 16, 2018
Patent Title: Device and method for treating vascular occlusion Aug. 14, 2018
Patent Title: Methods and apparatus for treating embolism Jun. 26, 2018
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Dec. 19, 2017
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Jul. 11, 2017
Patent Title: Methods and apparatus for treating embolism Aug. 09, 2016

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on NARI's company Twitter account

WallStreetBets

Number of mentions of NARI in WallStreetBets Daily Discussion

NARI News

Recent insights relating to NARI

CNBC Recommendations

Recent picks made for NARI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NARI

Corporate Flights

Flights by private jets registered to NARI